Balyasny Asset Management L.P.

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 1218710 Chicago, IL

Position in RCKT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$322,382

-$604,863 QoQ

Shares Held

94,264

-63.6% QoQ

Ownership

0.086%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#70

of 180 holders

Holding Since

Sep 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. RCKT ranks #159 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$322,382	94,264	-63.6%	Shares	Sole	2026-08-14
2026-03-31	$927,245	259,007	-35.4%	Shares	Sole	2026-05-15
2025-12-31	$1,406,478	400,706	-69.5%	Shares	Sole	2026-02-17
2025-09-30	$4,282,782	1,313,737	+896.7%	Shares	Sole	2025-11-14
2025-06-30	$322,924	131,806	-62.7%	Shares	Sole	2025-08-14
2025-03-31	$2,354,223	352,957	+931.9%	Shares	Sole	2025-05-15
2023-09-30	$700,860	34,205	+6210.9%	Shares	Sole	2023-11-14
2022-12-31	$10,606	542	-98.9%	Shares	Other	2023-02-14
2022-09-30	$794,328	49,770	—	Shares	Other	2022-11-15
No filing history on record for this holder in this stock.